![mechanism of action of glp 1 receptor agonist GLP-1 [25] GLP1 Receptor Agonists—Effects beyond Obesity](https://www.researchgate.net/publication/256289222/figure/fig1/AS:614177232142337@1523442671231/Mechanism-of-action-of-GLP-1-25.png)
mechanism of action of glp 1 receptor agonist GLP-1 [25] GLP1 Receptor Agonists—Effects beyond Obesity
Description
Individuals who used GLP-1RAs for 0.5, 1, and 1.5 years had IRRs close to 1.0, with no significant decrease in MACE risk at three years, although these estimates varied across specific treatment strategies defined by prior duration and subsequent exposure patterns
![mechanism of action of glp 1 receptor agonist GLP-1 [25] GLP1 Receptor AgonistsEffects beyond Obesity](https://www.mdpi.com/cells/cells-13-00065/article_deploy/html/images/cells-13-00065-g001.png)
The start of the GLP-1 era focused on the exciting transformations patients have made on these drugs
![mechanism of action of glp 1 receptor agonist GLP-1 [25] GLP1 Receptor AgonistsEffects beyond Obesity](https://www.frontiersin.org/files/Articles/997578/xml-images/fimmu-13-997578-g001.webp)
brought about an increase in blood glucose over a 90 minute period
![mechanism of action of glp 1 receptor agonist GLP-1 [25] GLP1 Receptor AgonistsEffects beyond Obesity](https://www.frontiersin.org/files/Articles/1033479/xml-images/fendo-13-1033479-g001.webp)
DOI: 10.1016/j.drugalcdep.2024.112424,
![mechanism of action of glp 1 receptor agonist GLP-1 [25] GLP1 Receptor AgonistsEffects beyond Obesity](https://www.researchgate.net/publication/380879316/figure/fig1/AS:11431281256002733@1719453628605/Mechanism-of-action-of-GLP-1-agonists.png)
Is once-weekly glp-1 receptor agonist a reasonable option for glucocorticoid-induced hyperglycemia
![mechanism of action of glp 1 receptor agonist GLP-1 [25] GLP1 Receptor AgonistsEffects beyond Obesity](https://em.huatengsci.com/upload/202304/23/202304231920227793.png)
